Laurion Capital Management LP Solid Biosciences Inc. Transaction History

Laurion Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.43 - $1.24 $497,338 - $1.43 Million	1,156,600 New	1,156,600 $712,000
Q2 2018 Aug 13, 2018	SELL	$7.33 - $43.15 $1.58 Million - $9.33 Million	-216,200 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$7.19 - $33.17 $1.55 Million - $7.17 Million	216,200 New	216,200 $1.62 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $53.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.